Document Type: Psychiatric Progress Note
Date of Service/Receive Date: January 17, 2022 13:01 EST
Document Status: Auth (Verified)
Document Title: BT1 Progress Note
Performed by: Waters, Amy – MD,Res,Psychiatry on January 17, 2022 13:05 EST
Verified by: Waters, Amy – MD,Res,Psychiatry on January 17, 2022 13:05 EST
Encounter info: 40020205734, JBHH, Inpatient, 1/14/2022 –
* Final Report *
BT1 Progress Note
JACK_FL
Patient: SOLA, EDUARDO MRN: 5561999 FIN: 40020205734
Age: 28 years Sex: Male DOB: 1/23/1993
Associated Diagnoses: None
Author: Waters, Amy – MD,Res,Psychiatry
Service performed as a moonlighter
Legal Status: Patient is voluntary and capacitated.
ID:
Patient is a 28 y/o male with no formal pphx who presented to crisis voluntarily brought by family due to worsening mood sx and SI, admitted voluntarily for stabilization.
HPI:
Patient seen during morning rounds, case discussed with treatment team.
Per nursing, no acute events overnight. Pt adherent with meds and vitals, no behavioral issues.
Pt reports last night he was sleepy after taking meds but still had trouble falling asleep, received Ativan 1mg PRN with good benefit. He remains anxious and depressed with SI, but feels safe in the hospital and tolerating meds w/o SE. Agrees to continue titrating.
Target Symptoms:
Quality – mood swings, SI
Severity – severe; danger to self
Context – stress, no past psychiatric tx
Modifying factors – hospitalization, medications, rest
Associated signs & symptoms – as per HPI & MSE
Based on symptoms and behaviors described above :
-There is evidence of symptoms and behavior reflecting impairment, and continued treatment in an Inpatient setting is warranted at this time
-The patient is in continued need of psychiatric hospitalization , no less restrictive alternative is presently available
-Pt continues to meet criteria for inpatient admission to BH Unit
ROS:
Constitutional: denies fever or headache
Cardiac: denies chest pain or palpitations
Pulmonary: denies cough or SOB
GI: denies diarrhea or constipation
GU: denies dysuria or hematuria
MSK: denies myalgias
Neuro: denies tremors or paraesthesias
Vital Signs:
Vitals Signs/Measurements
Temperature Oral: 36.6 DegC Low
Peripheral Pulse Rate: 89 bpm
Respiratory Rate: 18 br/min
Systolic Blood Pressure: 108 mmHg
Diastolic Blood Pressure: 63 mmHg
SpO2: 99 %
Labs:
WBC Count: 9.7 x10(3)/mcL (01/15/22)
RBC Count: 5.79 x10(6)/mcL High (01/15/22)
Hemoglobin: 17.7 g/dL High (01/15/22)
Hematocrit: 52.1 % High (01/15/22)
MCV: 90 fL (01/15/22)
MCH: 30.6 pg (01/15/22)
MCHC: 34 g/dL (01/15/22)
RDW-CV: 11.7 % (01/15/22)
Platelet Count: 307 x10(3)/mcL (01/15/22)
MPV: 10.6 fL (01/15/22)
NRBC%: 0 /100WBC (01/15/22)
NRBC%: 0 /100WBC (01/15/22)
NRBC(Abs): 0 x10(3)/mcL (01/15/22)
NRBC(Abs): 0 x10(3)/mcL (01/15/22)
Neutrophil (%): 73.7 % High (01/15/22)
Lymphocyte (%): 18.7 % (01/15/22)
Monocyte (%): 6 % (01/15/22)
Eosinophil (%): 0.5 % (01/15/22)
Basophil (%): 0.8 % (01/15/22)
Immature Granulocyte (%): 0.3 % (01/15/22)
Absolute Neutrophil: 7.1 x10(3)/mcL High (01/15/22)
Absolute Lymphocyte: 1.8 x10(3)/mcL (01/15/22)
Absolute Monocyte: 0.6 x10(3)/mcL (01/15/22)
Absolute Eosinophil: 0.05 x10(3)/mcL Low (01/15/22)
Absolute Basophil: 0.08 x10(3)/mcL (01/15/22)
Absolute Immature Granulocyte: 0.03 x10(3)/mcL (01/15/22)
Slide Review: Not Indicated (01/15/22)
TSH: 0.559 mcIU/mL (01/15/22)
Color: Yellow. (01/15/22)
Clarity: Turbid. Abnormal (01/15/22)
Specific Gravity: 1.02 (01/15/22)
Specific Gravity: 1.02 (01/15/22)
Urine pH: 7 (01/15/22)
Urine pH: 7 (01/15/22)
Protein: Negative: (01/15/22)
Glucose: Negative; (01/15/22)
Ketones: Negative: (01/15/22)
Bilirubin: Negative: (01/15/22)
Blood: Negative: (01/15/22)
Urobilinogen: Negative; (01/15/22)
Nitrites: Negative: (01/15/22)
Leukocyte Esterase: Negative: (01/15/22)
Urine Microscopic: Indicated Abnormal (01/15/22)
Urine WBC’s: <1 (01/15/22)
Urine WBC’s: <1 (01/15/22)
Urine RBC’s: 1 /HPF (01/15/22)
Urine RBC’s: 1 /HPF (01/15/22)
Bacteria: 0. (01/15/22)
Bacteria: 0. (01/15/22)
UA Amorph Phos: Present Abnormal (01/15/22)
Triphosphate Crystal: Present Abnormal (01/15/22)
SARS CoV 2 RNA, RT PCR: Negative, (01/15/22)
Cocaine & Metabolites: Not Detected (01/16/22)
Cannabinoid: Presumptive Pos Abnormal (01/16/22)
Benzodiazepine Class: Not Detected (01/16/22)
Opiate Class: Not Detected (01/16/22)
Amphetamine Class: Not Detected (01/16/22)
U Phencyclidine: Not Detected (01/16/22)
U Barbiturate Class: Not Detected (01/16/22)
U Methadone: Not Detected (01/16/22)
POC SARS CoV-2 Antigen: Negative` (01/15/22)
Medication List:
Medications (6) Active
Scheduled: (2)
divalproex 500 mg Tab EC/DR 500 mg 1 tab, ORAL, BID
QUEtiapine IR 200 mg Tab 200 mg 1 tab, ORAL, BEDTIME
Continuous: (0)
PRN: (4)
hydrOXYzine pamoate 50 mg Cap 50 mg 1 cap, ORAL, Q6H
LORazepam 1 mg Tab 1 mg 1 tab, ORAL, BEDTIME
LORazepam 2 mg/mL Inj 1 mL 2 mg 1 mL, IM, Q6H
nicotine 2 mg Loz 2 mg 1 lozenge, TRANSMUCOSAL, Q2H
MSE:
Appearance/Behavior: appears stated age, fair hygiene / calm, cooperative
Orientation: AAOx3
Speech: clear, coherent, normal rate and tone
Eye Contact: good
Motor Activity: no PMR/PMA, no dystonic/tardive movements
Mood/Affect: anxious, depressed / mood congruent
Thought Process: goal directed
Thought content:
– Hallucinations: denies AVH, does not appear RTIS
– Delusions/Preoccupations: none elicited
– SI/HI: denies
Insight/Judgment: limited/limited
Attention/Concentration: fair/fair
Memory: appears grossly intact
Level of risk: High
Justification for continued stay:
– Patient remains symptomatic and in need of further inpatient treatment and stabilization. Patient at risk of re-hospitalization or worsening of psychiatric symptoms in less restrictive environment.
Counseling provided:
– Diagnostic results/impressions and/or recommended studies
– Risks and benefits of treatment options
– Instruction for management/treatment and/or follow-up
– Importance of compliance with chosen treatment options
– Risk Factor Reduction
– Patient Education
– Prognosis
Coordination of care provided with:
– Nursing Staff
– Treatment Team
– Case manager
– Physician/s
Diagnoses
Bipolar disorder, unspecified (F31.9)
Anxiety disorder, unspecified (F41.9)
End of Diagnoses List
Plan
1. Legal Status: patient is voluntary and capacitated.
2. Patient continues to require 24 hour observation, nursing care, and inpatient treatment and cannot be treated in a less restrictive environment.
3. Patient was educated about reasons for prescribing the below listed medications, their expected benefits as well as potential side effects and relevant risks
4. Medications:
Medications (6) Active
Scheduled: (2)
divalproex 500 mg Tab EC/DR 500 mg 1 tab, ORAL, BID
QUEtiapine IR 200 mg Tab 200 mg 1 tab, ORAL, BEDTIME
Continuous: (0)
PRN: (4)
hydrOXYzine pamoate 50 mg Cap 50 mg 1 cap, ORAL, Q6H
LORazepam 1 mg Tab 1 mg 1 tab, ORAL, BEDTIME
LORazepam 2 mg/mL Inj 1 mL 2 mg 1 mL, IM, Q6H
nicotine 2 mg Loz 2 mg 1 lozenge, TRANSMUCOSAL, Q2H
5. Tobacco Cessation: NRT
6. Nursing Orders: encourage compliance with treatment plan, ADLs, groups
7. Labs/Imaging: reviewed as above
8. Consults: none indicated at this time
9. Court Date: n/a
10. Social Work: evaluation for disposition and follow-up
Clinical oversight provided by Dr. Dreize
Signature Line
Author: Waters, Amy – MD,Res,Psychiatry On: 01/17/2022 13:05 EST
Sent for Review: Dreize, Richard Michael – MD,Attn,Psychiatry